Criteria for deciding cost-effectiveness for expensive new anti-cancer agents.
Sarin
Rajiv
R
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents